Spironolactone to treat hypertension in end-stage renal disease : analysis of effectiveness and safety

Spironolactone to treat hypertension in end-stage renal disease : analysis of effectiveness and safety

Purpose: Cardiovascular events and complications are the major causes of death in patients with end-stage renal disease (ESRD)¹⁻³. Antihypertensive agents that block the renin-angiotensin-aldosterone system (RAAS) are considered first-line therapy in patients with ESRD as these patients have a prope...

Full description

Bibliographic Details
Main Author:	Smith, Amber Lanae
Format:	Others
Language:	en_US
Published:	2014
Subjects:	End-stage renal disease Spironolactone Hypertension Safety Efficacy Blood pressure
Online Access:	http://hdl.handle.net/2152/22994

Similar Items

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
by: Catherine J. Leader, et al.
Published: (2020-05-01)

Renal transplant in patient of end-stage renal disease with severe pulmonary hypertension
by: Prabhucharan Rangineni, et al.
Published: (2017-01-01)

Role of spironolactone in patients with resistant hypertension: A narrative review
by: Geeta Sheth, et al.
Published: (2021-01-01)

Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change
by: Sudeep R. Aryal, et al.
Published: (2021-09-01)

The Effect of Spironolactone on Control of Pulmonary Hypertension in Patients with Obstructive Pulmonary Disease
by: Mohammad Emami, et al.
Published: (2019-01-01)

Disease characteristics and outcomes in patients with chronic kidney disease and type 2 diabetes: a matched cohort study of spironolactone users and non-users
by: Michael Blankenburg, et al.
Published: (2020-02-01)

Hemodialysis efficacy in patients with end stage renal disease (ESRD) in Gorgan, Northern Iran (2008)
by: Shariati AR (MSc), et al.
Published: (2010-03-01)

Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model
by: Chun-Cheng Wang, et al.
Published: (2019-09-01)

Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease
by: Chen-Ta Yang, et al.
Published: (2018-11-01)

Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles
by: Renata Cunha de Resende, et al.

Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis
by: Zeng Q, et al.
Published: (2019-05-01)

Spironolactone-Induced Agranulocytosis: A Case Report
by: Shu-Hwa Hsiao, et al.
Published: (2003-11-01)

Inpatient Management of Blood Pressure and Fluid Overload in Patients With End-Stage Renal Disease on Hemodialysis
by: Jasensky, Alex, et al.
Published: (2014)

Severe pulmonary hypertension in a young patient with end-stage renal disease on chronic hemodialysis
by: Sharma Satyavan, et al.
Published: (2010-01-01)

Protective Effect of Spironolactone on Endothelial-to-Mesenchymal Transition in HUVECs via Notch Pathway
by: Xiao Chen, et al.
Published: (2015-04-01)

The Association between Human Leukocyte Antigens and Hypertensive End-Stage Renal Failure among Yemeni Patients
by: Mogahid Y. Nassar, et al.
Published: (2015-05-01)

The Association between Human Leukocyte Antigens and Hypertensive End-Stage Renal Failure among Yemeni Patients
by: Mogahid Y. Nassar, et al.
Published: (2015-05-01)

Arterial hypertension, cardiovascular remodeling and plasma level of osteopontin in patients with end-stage kidney disease on hemodialysis
by: V. A. Vizir, et al.
Published: (2014-12-01)

White-coat hypertension and incident end-stage renal disease in patients with non-dialysis chronic kidney disease: results from the C-STRIDE Study
by: Qin Wang, et al.
Published: (2020-06-01)

ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)

FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
by: Alexandra Poinas, et al.
Published: (2020-06-01)

Neurofibromatosis with Bilateral Renal Artery Stenosis and End Stage Renal Disease : Case Report
by: Mohamed Al-Rawahi, et al.
Published: (2009-08-01)

Compliance of End Stage Renal Disease Patients on Haemodialysis
by: Mohammad Nadeem
Published: (2011-06-01)

Diuretic Effect of Prosopis farcta in Comparison with Spironolactone and Hydrochlorothiazide in Hypertensive Rats
by: Zana M.Raoof, et al.
Published: (2020-06-01)

The influence of spironolactone on the serum electrolytes balance and renal cortical magnesium and calcium contents in cisplatin – treated rabbits
by: Abdelgayoum A. Abdel-Gayoum, et al.
Published: (2018-05-01)

Pulmonary hypertension and post-operative outcome in renal transplant: A retrospective analysis of 170 patients
by: Vipin Kumar Goyal, et al.
Published: (2018-01-01)

Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis
by: Mengdi Xia, et al.
Published: (2021-01-01)

Varicella infections in patients with end stage renal disease: a systematic review
by: Chong Yau Ong, et al.
Published: (2018-07-01)

Efficacy and safety of topical spironolactone 5% cream in the treatment of acne: A pilot study
by: Azin Ayatollahi, et al.
Published: (2021-09-01)

The Impact of Hemodialysis Frequency and Duration on Blood Pressure Management and Quality of Life in End-Stage Renal Disease Patients
by: Mohammad Ali Shafiee, et al.
Published: (2017-09-01)

Crosssectional study of quality of life after renal transplant in end stage renal disease
by: R C Das, et al.
Published: (2014-01-01)

Causes of end-stage renal disease in children
by: Esfahani ST, et al.
Published: (1999-09-01)

Iatrogenic Iron Overload in an End Stage Renal Disease Patient
by: Majd M. Aldwairi, et al.
Published: (2020-06-01)

Competing Risk Analyses of Patients with End-Stage Renal Disease
by: Reza Tabrizi, et al.
Published: (2015-11-01)

Pruritus among End-Stage Renal Failure Patients on Hemodialysis
by: Jamal Arshad, et al.
Published: (2000-01-01)

Self-management and associated factors among patients with end-stage renal disease undergoing hemodialysis at health facilities in Addis Ababa, Ethiopia
by: Gela D, et al.
Published: (2018-11-01)

Anaesthetic management of a patient with severe pulmonary arterial hypertension for renal transplantation
by: M N Chidananda Swamy, et al.
Published: (2017-01-01)

Extent of malnutrition in end-stage renal disease patients
by: Nazar Chaudhary Muhammad Junaid, et al.
Published: (2014-04-01)

Recent Advances in the Management of End-Stage Renal Disease (ESRD) in Children
by: Richard N. Fine
Published: (2019-07-01)